“[Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy]” (2015) Farmeconomia. Health Economics and Therapeutic Pathways, 16(4), pp. 93–102. doi:10.7175/fe.v16i4.1221.